Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
Susan O’Brien(The University of Texas MD Anderson Cancer Center), Richard R. Furman, Steven Coutré, Jeff P. Sharman(Willamette Valley Cancer Institute and Research Center), Jan A. Burger(The University of Texas MD Anderson Cancer Center), Kristie A. Blum(The Ohio State University), Barbara Grant(University of Vermont), Donald Richards(Texas Oncology), Morton Coleman, William G. Wierda(The University of Texas MD Anderson Cancer Center), Jeffrey A. Jones(The Ohio State University), Weiqiang Zhao(The Ohio State University), Nyla A. Heerema(The Ohio State University), Amy J. Johnson(The Ohio State University), Raquel Izumi(Pharmacyclics (United States)), Ahmed Hamdy(Pharmacyclics (United States)), Betty Chang(Pharmacyclics (United States)), Thorsten Graef(Pharmacyclics (United States)), Fong Clow(Pharmacyclics (United States)), Joseph J. Buggy(Pharmacyclics (United States)), Danelle F. James(Pharmacyclics (United States)), John C. Byrd(The Ohio State University)
Cited by 465
Abstract
Related Papers
No related papers found
Powered by citation graph analysis